Parkinson’s disease has long been defined by the slow, relentless loss of dopamine-producing neurons, with treatments focused ...

Maureen Sideris, seated, with her sister Marion, receiving the 8th of 9 immunotherapy infusions during successful treatment for early-stage gastroesophageal junction cancer at Memorial Sloan Kettering ...

Results from a groundbreaking clinical trial could soon change the way certain types of cancers are treated. A study published Sunday in the New England Journal of Medicine found that immunotherapy ...

An international research team with strong participation from DTU has developed a new biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and ...

Researchers conducted a systematic review of studies assessing the cost-effectiveness or cost-utility of adjuvant immunotherapy for treating various types of cancer.

Cardiologists have spent decades trying to stabilize the fatty plaques that clog arteries, but a new wave of immunotherapy is going after the diseased cells at the heart of the problem. In mice, an ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

Lunit’s SCOPE IO artificial intelligence (AI)-based pathology platform has demonstrated its ability to generate biomarkers that predict patients’ response to immunotherapy across cancer types. Data ...

Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.

Healthcare professionals may use immunotherapy as part of the treatment for someone with Hodgkin’s lymphoma. They may also use it as part of palliative therapy to improve a person’s quality of life ...

Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against heart disease. The antibody-based therapy could complement ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted a second fast-track designation for a type 1 diabetes immunotherapy. The FDA will allow ...